Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Objective: Erythroderma is an uncommon and severe skin disorder with many underlying causes, and identifying its etiology can facilitate further treatments. This study was performed to evaluate the clinical profile and etiology of erythroderma. Methods: We studied 136 consecutive patients with erythroderma with respect to the epidemiological, clinical, biological, and histological data; treatments; and outcomes from 2011 to 2021. The analyses of qualitative data were performed with the chi-squared test or Fisher’s exact test. The groups of quantitative data were compared using a t-test or analysis of variance. Results: The patients’ mean age in this study was 65.00 ± 16.51 years, with a male:female ratio of 5.8:1.0. Acute onset occurred in 19.85% of the patients and was associated with drug reactions (P=0.002). The mean length of stay was 19.18 ± 9.75 days. Clinical findings were dominated by pruritus (99.26%), fever (32.35%), edema (60.29%), nail changes (10.29%), arrhythmia (11.76%), and superficial lymphadenopathy (41.91%). Skin biopsies revealed the cause in 25% of the patients. The most common causative factor was pre-existing dermatoses (78.68%), followed by drug reactions (11.03%), malignancies (5.88%), and undetermined etiology (4.41%). Among the pre-existing dermatoses, eczema was the most common etiology (33.88%). We also found that psoriasis (30.15%), solar dermatitis, hypereosinophilic syndrome, atopic dermatitis, scabies, pemphigus foliaceus, and pityriasis rubra pilaris could be causes of erythroderma. In the drug-induced group, anticonvulsants were the most frequently implicated drug in our study (26.67%). Fever was mostly found in patients with psoriasis (P=0.022). Nail changes and arthralgia were more prevalent among patients with psoriasis (P<0.001). Eosinophilia and an increased immunoglobulin E concentration were associated with hypereosinophilic syndrome (P = 0.005) and eczema (P = 0.032), respectively. Infection was mostly found in patients with psoriasis (P = 0.007). The infection rate was significantly higher in patients with abnormal liver function (P = 0.0005). Conclusion: Most of the clinical features of erythroderma are unspecific with the exception of fever, nail changes, and arthralgia, which were mostly found in patients with psoriasis. Clinicohistopathological examination helps to establish the etiology of erythroderma.
Objective: Erythroderma is an uncommon and severe skin disorder with many underlying causes, and identifying its etiology can facilitate further treatments. This study was performed to evaluate the clinical profile and etiology of erythroderma. Methods: We studied 136 consecutive patients with erythroderma with respect to the epidemiological, clinical, biological, and histological data; treatments; and outcomes from 2011 to 2021. The analyses of qualitative data were performed with the chi-squared test or Fisher’s exact test. The groups of quantitative data were compared using a t-test or analysis of variance. Results: The patients’ mean age in this study was 65.00 ± 16.51 years, with a male:female ratio of 5.8:1.0. Acute onset occurred in 19.85% of the patients and was associated with drug reactions (P=0.002). The mean length of stay was 19.18 ± 9.75 days. Clinical findings were dominated by pruritus (99.26%), fever (32.35%), edema (60.29%), nail changes (10.29%), arrhythmia (11.76%), and superficial lymphadenopathy (41.91%). Skin biopsies revealed the cause in 25% of the patients. The most common causative factor was pre-existing dermatoses (78.68%), followed by drug reactions (11.03%), malignancies (5.88%), and undetermined etiology (4.41%). Among the pre-existing dermatoses, eczema was the most common etiology (33.88%). We also found that psoriasis (30.15%), solar dermatitis, hypereosinophilic syndrome, atopic dermatitis, scabies, pemphigus foliaceus, and pityriasis rubra pilaris could be causes of erythroderma. In the drug-induced group, anticonvulsants were the most frequently implicated drug in our study (26.67%). Fever was mostly found in patients with psoriasis (P=0.022). Nail changes and arthralgia were more prevalent among patients with psoriasis (P<0.001). Eosinophilia and an increased immunoglobulin E concentration were associated with hypereosinophilic syndrome (P = 0.005) and eczema (P = 0.032), respectively. Infection was mostly found in patients with psoriasis (P = 0.007). The infection rate was significantly higher in patients with abnormal liver function (P = 0.0005). Conclusion: Most of the clinical features of erythroderma are unspecific with the exception of fever, nail changes, and arthralgia, which were mostly found in patients with psoriasis. Clinicohistopathological examination helps to establish the etiology of erythroderma.
Psoriasis (PsO) and atopic dermatitis (AD have much in common: both diseases are widespread, characterized by a chronic relapsing course, primarily affect the skin and lead to a quality reduction of life of patients, regardless of their age. The pathogenesis of these two dermatoses, which are the most common in the practice of a pediatric dermatologist, is quite different. PsO is a chronic inflammatory skin disease, the pathogenesis of which is associated with the involvement of the Th1 pathway: Th17 cells and the IL-23/IL-17 axis. AD, in turn, is usually associated with high levels of IL-4, IL-5, IL-13, IL-31 and IFN-γ produced by activated T-helper 2 (Th2) cells. The clinical symptoms and immunopathological responses of these two skin conditions tend to differ. However, patients with PsO may sometimes present with a skin rash resembling AD combined with intense itching and laboratory increase in immunoglobulin E (IgE) which may indicate the need to change the paradigm of dominance of only one type of T-inflammation in patients with these diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.